×
OpGen Receivables 2014-2024 | OPGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
OpGen receivables from 2014 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
OpGen Receivables 2014-2024 | OPGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
OpGen receivables from 2014 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
CVS Health (CVS)
$75.9B
Elevance Health (ELV)
$65B
Cencora (COR)
$56.2B
DiDi Global (DIDIY)
$25.7B
Labcorp Holdings (LH)
$21.9B
Natera (NTRA)
$18.5B
BioMerieux (BMXMF)
$17.1B
EUROFINS SCIENT (ERFSF)
$15.2B
ICON (ICLR)
$15B
CochLear (CHEOY)
$13.6B
Solventum (SOLV)
$12.7B
Medpace Holdings (MEDP)
$12.6B
Revvity (RVTY)
$11.1B
Viatris (VTRS)
$10.8B
Avantor (AVTR)
$9.5B
Sonic Healthcare (SKHHY)
$9.1B
Charles River Laboratories (CRL)
$8.8B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$7B
Bausch + Lomb (BLCO)
$5.2B
Amplifon S.p.A (AMFPF)
$5.1B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.4B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.6B
GeneDx Holdings (WGS)
$2.6B
Concentras Parent (CON)
$2.6B
Alignment Healthcare (ALHC)
$2.3B
Progyny (PGNY)
$2B